Cite
HARVARD Citation
Cesaroni, M. et al. (2021). Suppression of Serum Interferon‐γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus. Arthritis & rheumatology. 73 (3), pp. 472-477. [Online].